Serum Institute Archives

Cyril Amarchand Mangaldas advises Serum Institute on sale of stake held in Biocon Biologics and subscription of shares in Biocon Limited, through share swap

Cyril Amarchand Mangaldas advised Serum Institute on the proposed sale of its stake in Biocon Biologics to Biocon and the simultaneous subscription of shares in Biocon Limited through a share swap transaction valued at ₹2,250 crore. The deal marks a significant restructuring in India’s biopharmaceutical sector.

Case Briefs High Courts

[Covishield Vaccine] Content against Adar Poonawala – Serum Institute prima facie defamatory: Bombay High Court

Bombay High Court pointed at the alleged ban on Covishield/Astra Zenica vaccine in European countries to be a misconception while stating the correct facts that it was a temporary measure.

Case Briefs Supreme Court

Two persons died after first dose of Covishield due to severe adverse effects following immunization; Supreme Court issues notice Central Government

Supreme Court: In a case alleging death of two young girls due to side-effect of Covishield, the Division Bench comprising Dinesh Maheshwari

Case Briefs High Courts

Bom HC | “Serum Institute coined the term ‘Covishield’, took substantial steps towards development and manufacture”: Court finds no merit in Cutis Biotech’s passing off action

Bombay High Court: The Division Bench of Nitin Jamdar and C.V Bhadang, JJ., upheld the order of the District Court refusing to